Please login to the form below

Not currently logged in
Email:
Password:

Eurocine Vaccines appoints chief scientific officer and chief business officer

Anna-Karin Maltais and Emma Berglund both receive promotions

Eurocine Vaccines has appointed Dr Anna-Karin Maltais as chief scientific officer and promoted business development manager Emma Berglund to chief business officer.

Dr Maltais, who also becomes head of R&D, takes over from Professor Jorma Hinkula, who has returned to his previous position as professor at the University of Linköping in Sweden.

In her new role, Dr Maltais will oversee Eurocine's vaccines development programme, which includes Immunose – a nasal vaccine for influenza.

“Dr Maltais has extensive experience in vaccine development from both academia and industry,” said the company's CEO Hans Arwidsson.

“Her expertise in vaccine delivery and adjuvants is extremely valuable to the company and with her industry background we can run our projects with an even stronger commercial focus.”

This includes several years at Cyto Pulse Sciences, where she served as manager EU operations and then VP, corporate development.

Berglund had been in her previous position since 2009, and has prior business development experience at both Biovitrum and Avaris.

25th September 2012

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics